It was estimated in 2002 that the size of traditional Chinese medicine (TCM) in China would be around $ five billionth A decade of changes in Chinese laws, Chinese pharmaceutical industry liberalization changed Chinese lifestyle and demographics, and the Chinese pharmaceutical research and development facilities were factors that explain the huge market potential of TCM in China. Multinational corporations might want to enter this market have to deal with inadequate protection of intellectual property … Read more »

It was estimated in 2002 that the size of traditional Chinese medicine (TCM) in China would be around $ five billionth A decade of changes in Chinese laws, Chinese pharmaceutical industry liberalization changed Chinese lifestyle and demographics, and the Chinese pharmaceutical research and development facilities were factors that explain the huge market potential of TCM in China. Multinational corporations might want to enter this market have to deal with inadequate protection of intellectual property rights, corruption in health insurance reimbursement complex regulatory procedures and underdeveloped pricing, quoting, and sales practice.
«Hide

from
Ali Farhoomand,
Scarlet Chan,
Shirley Chan
21 pages.
Release Date: 18, March 2005. Prod #: HKU391-PDF-ENG
Chinese Medicine in an Emerging Market HBR case solution

[related_post themes="flat"]